NCT02546856 - Safety and Effectiveness of Drug up Titration by Nurses Specialized in Heart Failure (HF) Patients | Biotech Hunter

Enrollment

320

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

April 1, 2019

Conditions

Heart Failure

Interventions

OTHER

Heart Failure (HF) nurse up-titration

"Up-titration of Beta-Blocker (BB), Angiotensin Converting Enzyme Inhibitor (ACEI), Angiotensin II Receptor Blocker (ARB) and Mineralocorticoid Receptor Antagonist (MRA) in Heart Failure De Novo patients with Left Ventricular Ejection Fraction (LVEF)≤ 40%, following a protocol based on 2012 European Society of Cardiology (ESC) Heart Failure (HF) guidelines with cardiologist prescription and support."

OTHER

Heart Failure (HF) cardiologist up-titration

"Up-titration of Beta-Blocker (BB), Angiotensin Converting Enzyme Inhibitor (ACEI), Angiotensin II Receptor Blocker (ARB) and Mineralocorticoid Receptor Antagonist (MRA) in Heart Failure De Novo patients with Left Ventricular Ejection Fraction (LVEF)≤ 40%, following a protocol based on 2012 European Society of Cardiology (ESC) Heart Failure (HF) guidelines. Drugs are prescribed and titrated by the cardiologist."

Trial Locations (1)

48960

Hospital de usansolo-Galdakao, Usansolo